- Report
- February 2024
- 180 Pages
Global
From €4642EUR$4,969USD£3,927GBP
- Report
- March 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Report
- March 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1401EUR$1,500USD£1,185GBP
- Report
- February 2024
- 118 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- April 2023
- 110 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- April 2023
- 111 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- April 2023
- 129 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- August 2024
- 80 Pages
Japan
From €3270EUR$3,500USD£2,766GBP
- Report
- August 2023
- 74 Pages
Canada
From €3270EUR$3,500USD£2,766GBP
- Report
- August 2023
- 73 Pages
Israel
From €3270EUR$3,500USD£2,766GBP
- Report
- October 2023
- 188 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- June 2024
- 74 Pages
From €3223EUR$3,450USD£2,727GBP
- Report
- November 2023
- 176 Pages
Global
From €4157EUR$4,450USD£3,517GBP
- Report
- May 2023
- 57 Pages
Global
From €3732EUR$3,995USD£3,157GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1868EUR$2,000USD£1,581GBP
- Drug Pipelines
- July 2023
- 144 Pages
Global
From €14009EUR$14,995USD£11,851GBP
- Report
- January 2024
- 250 Pages
Global
€4666EUR$4,995USD£3,948GBP
- Report
- June 2018
- 15 Pages
Global
From €9342EUR$10,000USD£7,903GBP
- Report
- June 2018
- 11 Pages
Global
From €9342EUR$10,000USD£7,903GBP

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more